The Health Resources and Services Administration (HRSA) is accepting applications for the fiscal year (FY) 2022 Increasing Uptake of Long-Acting Injectable Antiretrovirals Among People with HIV.
Donor Name: Health Resources and Services Administration (HRSA)
State: All States
County: All Counties
Type of Grant: Grant
Deadline: 06/21/2022
Size of the Grant: $2,000,000
Grant Duration: 4 years
Details:
This program is supported with funding from the U.S. Department of Health and Human Services (HHS) Minority HIV/AIDS Fund (MHAF) and the HRSA HIV/AIDS Bureau (HAB) Special Projects of National Significance (SPNS) Program. The purpose of this program is to develop, implement, and evaluate protocols for the successful use of long-acting injectable (LAI) antiretroviral (ARV) medication within clinical practice.
The main objective of this program is to develop and implement protocols for the successful use of LAI ARV medication within clinical practice. This program will fund 1 organization to serve as the Coordination and Evaluation Provider (CEP). The CEP must have the capacity and infrastructure (e.g., staffing/personnel, training, clinical systems, data collection and reporting, protocol and implementation evaluation) to support the development, implementation, and refinement of LAI ARV medication administration protocols with the goal of replicating and expanding successful protocols.
The recipient will solicit and sub-award up to 10 demonstration sites (sub-recipients) to implement these co-developed protocols and collect data from direct patient care, with priority given to entities located within EHE jurisdictions. HRSA anticipates that through evaluation and scale-up of LAI ARV medication administration protocols, patients with historic difficulty accessing or continuing oral HIV therapy can be bridged to this treatment modality, thus improving viral suppression and retention in care, especially among racial and ethnic minorities.
Funding Information
- HRSA estimates $1,500,000 to be available in year 1 to fund 1 recipient. Funding for years 2 and 3 is estimated at up to $2,000,000 each year, and funding for the final project year, year 4, is estimated at up to $1,500,000.
Period of Performance
- The period of performance is September 1, 2022, through August 31, 2026 (4 years).
Eligibility Criteria
Eligible applicants include entities eligible for funding under Parts A-D of Title XXVI of the Public Health Service (PHS) Act, including public and nonprofit private entities, state and local governments, academic institutions; local health departments; nonprofit hospitals and outpatient clinics; colleges and universities; community health centers receiving support under Section 330 of the PHS Act; faith-based and community-based organizations; and Indian Tribes or Tribal organizations with or without federal recognition. Proof of applicant status (e.g., proof of non-profit status) may be requested or required.
For more information, visit Grants.gov.
